HEPSA

Your search returned 5 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Opioid Agonist Therapy linked to increased HCV treatment rates in people who inject drugs by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2021
Online resources:
Availability: Items available for loan: Library (1).
2.
HCV treatment response high regardless of recent injection drug use by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1)Call number: 3.1.
3.
Low cost needle and syringe programs reduce HCV transmission effectively by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1)Call number: 2.4.
4.
Outcomes of feasibilty study on DAAs in injection drug users by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2019
Online resources:
Availability: Items available for loan: Library (1).
5.
Integrating treatments for opioid use disorder and infectious diseases by Series: Infectious Disease AdvisorNew York Infectious Disease Advisor 2018
Online resources:
Availability: Items available for loan: Library (1)Call number: 3.1.
Pages

Powered by

Koha

Provided by

Hepatitis SA

Hosted by

Catalyst

Hepatitis SA acknowledges and respects the Kaurna people as the traditional custodians of the unceded ancestral land from which we work. We pay our respects to elders past and present.